Respira Therapeutics Enters into Agreement with Gossamer Bio
25 Sep 2025 //
PR NEWSWIRE
Respira Therapeutics to Present RT234 Phase 2b PAH Trial Results
19 May 2025 //
GLOBENEWSWIRE
Health tech company throws out overused name as it rebrands to Qnovia
16 Sep 2022 //
FIERCEPHARMA